189 related articles for article (PubMed ID: 19164566)
1. Bimodal modulation of the botulinum neurotoxin protein-conducting channel.
Fischer A; Nakai Y; Eubanks LM; Clancy CM; Tepp WH; Pellett S; Dickerson TJ; Johnson EA; Janda KD; Montal M
Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1330-5. PubMed ID: 19164566
[TBL] [Abstract][Full Text] [Related]
2. Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes.
Fischer A; Montal M
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10447-52. PubMed ID: 17563359
[TBL] [Abstract][Full Text] [Related]
3. Toosendanin: synthesis of the AB-ring and investigations of its anti-botulinum properties (Part II).
Nakai Y; Pellett S; Tepp WH; Johnson EA; Janda KD
Bioorg Med Chem; 2010 Feb; 18(3):1280-7. PubMed ID: 20044261
[TBL] [Abstract][Full Text] [Related]
4. Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes.
Fischer A; Montal M
J Biol Chem; 2007 Oct; 282(40):29604-11. PubMed ID: 17666397
[TBL] [Abstract][Full Text] [Related]
5. Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel.
Montal M
Toxicon; 2009 Oct; 54(5):565-9. PubMed ID: 19111565
[TBL] [Abstract][Full Text] [Related]
6. Cure of experimental botulism and antibotulismic effect of toosendanin.
Shi YL; Wang ZF
Acta Pharmacol Sin; 2004 Jun; 25(6):839-48. PubMed ID: 15169642
[TBL] [Abstract][Full Text] [Related]
7. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel.
Koriazova LK; Montal M
Nat Struct Biol; 2003 Jan; 10(1):13-8. PubMed ID: 12459720
[TBL] [Abstract][Full Text] [Related]
8. Substrate cleavage and duration of action of botulinum neurotoxin type FA ("H, HA").
Pellett S; Tepp WH; Lin G; Johnson EA
Toxicon; 2018 Jun; 147():38-46. PubMed ID: 29273248
[TBL] [Abstract][Full Text] [Related]
9. Molecular dissection of botulinum neurotoxin reveals interdomain chaperone function.
Fischer A; Montal M
Toxicon; 2013 Dec; 75():101-7. PubMed ID: 23396042
[TBL] [Abstract][Full Text] [Related]
10. Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells.
Lam KH; Perry K; Shoemaker CB; Jin R
Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32992561
[TBL] [Abstract][Full Text] [Related]
11. Toosendanin interferes with pore formation of botulinum toxin type A in PC12 cell membrane.
Li MF; Shi YL
Acta Pharmacol Sin; 2006 Jan; 27(1):66-70. PubMed ID: 16364212
[TBL] [Abstract][Full Text] [Related]
12. Synchronized chaperone function of botulinum neurotoxin domains mediates light chain translocation into neurons.
Fischer A
Curr Top Microbiol Immunol; 2013; 364():115-37. PubMed ID: 23239351
[TBL] [Abstract][Full Text] [Related]
13. Function-oriented synthesis applied to the anti-botulinum natural product toosendanin.
Nakai Y; Tepp WH; Dickerson TJ; Johnson EA; Janda KD
Bioorg Med Chem; 2009 Feb; 17(3):1152-7. PubMed ID: 19131252
[TBL] [Abstract][Full Text] [Related]
14. Primary cell culture for evaluation of botulinum neurotoxin antagonists.
Sheridan RE; Smith TJ; Adler M
Toxicon; 2005 Mar; 45(3):377-82. PubMed ID: 15683877
[TBL] [Abstract][Full Text] [Related]
15. Uptake of botulinum neurotoxin into cultured neurons.
Keller JE; Cai F; Neale EA
Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
[TBL] [Abstract][Full Text] [Related]
16. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
[TBL] [Abstract][Full Text] [Related]
17. Persistence of botulinum neurotoxin action in cultured spinal cord cells.
Keller JE; Neale EA; Oyler G; Adler M
FEBS Lett; 1999 Jul; 456(1):137-42. PubMed ID: 10452545
[TBL] [Abstract][Full Text] [Related]
18. Enhancing toxin-based vaccines against botulism.
Przedpelski A; Tepp WH; Zuverink M; Johnson EA; Pellet S; Barbieri JT
Vaccine; 2018 Feb; 36(6):827-832. PubMed ID: 29307477
[TBL] [Abstract][Full Text] [Related]
19. Translocation domain of botulinum neurotoxin A subtype 2 potently induces entry into neuronal cells.
Kohda T; Tsukamoto K; Torii Y; Kozaki S; Mukamoto M
Microbiol Immunol; 2020 Jul; 64(7):502-511. PubMed ID: 32301520
[TBL] [Abstract][Full Text] [Related]
20. Multiple domains of botulinum neurotoxin contribute to its inhibition of transmitter release in Aplysia neurons.
Poulain B; Wadsworth JD; Shone CC; Mochida S; Lande S; Melling J; Dolly JO; Tauc L
J Biol Chem; 1989 Dec; 264(36):21928-33. PubMed ID: 2574722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
